Institute Of Hematology And Blood Transfusion, Czech Republic
Clinical trials sponsored by Institute Of Hematology And Blood Transfusion, Czech Republic, explained in plain language.
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy called CART123 in 18 adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to recognize and attack cancer cells…
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Precision proton beam may boost transplant safety for tough blood cancers
Disease control Recruiting nowThis study tests a new way to prepare people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) for a stem cell transplant. Instead of standard full-body radiation, participants receive targeted proton radiation to the bone marrow, combined with chemoth…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated May 26, 2026 07:27 UTC